Peptide Research

Evidence-based coverage of peptide research, clinical trials, and emerging metabolic science.

Retatrutide Phase 3 results from the TRIUMPH-2 trial and retatrutide Canada research

02 Oct

Retatrutide Phase 3 Results: What the TRIUMPH-2 Trial Means for Canada

Explore the latest retatrutide Phase 3 results from TRIUMPH-2, weight-loss and A1C findings, Canadian clinical trials, and whether retatrutide is approved in Canada.

Laboratory scientist conducting peptide research for a 2026 retatrutide Phase 3 clinical study article

30 Sep

Retatrutide Phase 3 Results 2026: What Canadians Should Know

New TRIUMPH-2 Phase 3 data show substantial weight loss and A1C reductions with retatrutide. Here is what Canadians should know about the results, current trials, and regulatory status.